Skip to main content
Fresenius Medical Care AG & Co. KGaA logo

Fresenius Medical Care AG & Co. KGaA — Investor Relations & Filings

Ticker · FME ISIN · DE0005785802 LEI · 549300CP8NY40UP89Q40 F Human health and social work activities
Open in API
Filings indexed 1,534 across all filing types
Latest filing 2025-12-15 Major Shareholding Noti…
Country DE Germany
Listing F FME

About Fresenius Medical Care AG & Co. KGaA

https://www.freseniusmedicalcare.com/en…

Fresenius Medical Care is a leading global provider of products and services for individuals with renal diseases. The company delivers comprehensive dialysis care to patients with chronic kidney failure through an extensive network of outpatient clinics. Its core services include in-center hemodialysis, home hemodialysis (HHD), and peritoneal dialysis (PD). As a vertically integrated company, it also develops, manufactures, and distributes a wide array of products essential for kidney replacement therapy. This portfolio includes advanced dialysis machines, dialyzers, water treatment systems, and related disposables. The company's offerings extend to home therapy systems, critical care solutions for acute blood purification and therapeutic apheresis, and specialized pediatric dialysis treatments.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document is a formal 'Notification of Major Holdings' regarding Fresenius Medical Care AG, filed by BlackRock, Inc. It explicitly references 'Article 40, Section 1 of the WpHG' (German Securities Trading Act) and details changes in voting rights and shareholdings. This fits the definition of a 'Major Shareholding Notification' (MRQ), which tracks significant ownership changes.
2025-12-15 English
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document is a formal 'Voting Rights Announcement' regarding a change in major shareholding by BlackRock, Inc. in Fresenius Medical Care AG. It explicitly references 'Article 40, Section 1 of the WpHG' (German Securities Trading Act) and provides detailed tables on voting rights, instruments, and the chain of controlled undertakings. This fits the definition of a 'Major Shareholding Notification' (MRQ) as it details the crossing of ownership thresholds.
2025-12-12 English
: Release of a capital market information
Transaction in Own Shares Classification · 1% confidence The document is a formal disclosure by Fresenius Medical Care AG regarding the purchase of its own shares (share buyback) over a specific period (December 1 to December 5, 2025). It explicitly cites Regulation (EU) No. 596/2014 and provides a detailed table of transaction volumes, dates, and prices. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-12-08 English
Transaction in Own Shares 2025
Transaction in Own Shares Classification · 1% confidence The document is a formal notification regarding the acquisition or disposal of own shares (treasury shares) by Fresenius Medical Care AG, specifically citing Sec. 40 para. 1 sent. 2 WpHG. While the header mentions 'Voting rights Announcements', the content explicitly details the company's own share position (3.0561%) and the acquisition/disposal of its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-12-03 English
: Release of a capital market information
Transaction in Own Shares Classification · 1% confidence The document is a formal disclosure by Fresenius Medical Care AG regarding a share buyback program. It explicitly references 'Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014' and provides a detailed table of shares acquired, weighted average prices, and trading venues for a specific period. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2025-12-01 English
: Release of a capital market information
Transaction in Own Shares Classification · 1% confidence The document is a formal disclosure by Fresenius Medical Care AG regarding the repurchase of its own shares over a specific period (November 17-21, 2025). It explicitly cites Regulation (EU) No. 596/2014, which governs market abuse and requires disclosure of share buyback transactions. Since the document details the company's activity in buying back its own shares, it falls under the 'Transaction in Own Shares' category.
2025-11-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.